FDA Clearance Tracker · P200030
Gore Excluder Conformable AAA Endoprosthesis (CEXC)
Last checked: Nov 19, 2026Latest source record: Dec 22, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Dec 22, 2020
Approved
Time to decision
176 days
Received Jun 29, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P200030
- Device name
- Gore Excluder Conformable AAA Endoprosthesis (CEXC)
- Applicant
- W. L. Gore and Associates, Inc.
- Applicant location
- Phonix, AZ
- Received
- Jun 29, 2020
- Decided
- Dec 22, 2020
- Decision
- Approved
- Supplements
- 26 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for Gore Excluder Conformable AAA Endoprosthesis (EXCC)This device is indicated to exclude the aneurysm from the blood circulation in patients diagnosed with infrarenal abdominal aortic aneurysm (AAA) disease and who have appropriate anatomy as described below:1) Adequate iliac / femoral access;2) Infrarenal aortic neck treatment diameter range of 1632 mm;3) A minimum aortic neck length of 15 mm when proximal aortic neck angulation is =<60 degrees; and4) Iliac artery treatment diameter range of 825 mm and iliac distal vessel seal zone length of at least 10 mm.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MIH. The earliest in FDA's data is P990017, decided Sep 28, 1999.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for W. L. Gore and Associates, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- GORE®1 EXCLUDER® Conformable AAA Endoprosthesis (CEXC), GORE® EXCLUDER® Conformable AAA Endoprosthesis (EXCC)PMA supplement
P200030-S014 · Decided Apr 5, 2024 · 178 days after receipt · Panel Track
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
- GORE® ENFORM Biomaterial510(k)
K222919 · Decided Dec 19, 2022 · 84 days after receipt
Device type: Mesh, Surgical, Absorbable, Plastic And Reconstructive Surgery (OXF) · General & Plastic Surgery
- GORE Tri-Lumen Catheter510(k)
K180919 · Decided Oct 5, 2018 · 179 days after receipt
Device type: Catheter, Percutaneous (DQY) · Cardiology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.